Innate Pharma Stock
Innate Pharma Stock
We can see a decrease in the price for Innate Pharma. Compared to yesterday it has lost -€0.024 (-1.560%).
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | -1.560% | -3.069% | -3.929% | -16.428% | -0.915% | -44.772% | -47.361% |
| Nanobiotix | -0.950% | -3.813% | -1.128% | 481.152% | 74.346% | 377.762% | 172.951% |
| Poxel S.A. | 3.270% | 3.579% | 1.232% | -60.481% | -14.017% | -65.750% | -96.537% |
| Adocia | 0.050% | 4.692% | -4.657% | -41.156% | -39.818% | -35.098% | -58.321% |
